11.02.11
Milton Boyer, vice president of business development at OSO BioPharmaceuticals Manufacturing, has been elected to the board of directors at the Drug, Chemical and Associated Technology Association (DCAT). Mr. Boyer will serve a three-year term on the board.
DCAT is a business development association comprised of member companies that manufacture, distribute or provide services to the pharmaceutical, chemical and related industries.
Mr. Boyer has more than 20 years of experience in fine chemical and pharmaceutical business development. He has developed special expertise in APIs and narcotic raw materials. In addition to his board membership at DCAT, Mr. Boyer is a member of the International Society of Pharmaceutical Engineers (ISPE) and the American Association of Pharmaceutical Scientists (AAPS).
“We are delighted to have Mr. Boyer join the organization’s leadership,” said Margaret Timony, executive director DCAT. “He brings unique qualifications and experiences to his role that will help shape and support the organization’s programs and projects.”
DCAT is a business development association comprised of member companies that manufacture, distribute or provide services to the pharmaceutical, chemical and related industries.
Mr. Boyer has more than 20 years of experience in fine chemical and pharmaceutical business development. He has developed special expertise in APIs and narcotic raw materials. In addition to his board membership at DCAT, Mr. Boyer is a member of the International Society of Pharmaceutical Engineers (ISPE) and the American Association of Pharmaceutical Scientists (AAPS).
“We are delighted to have Mr. Boyer join the organization’s leadership,” said Margaret Timony, executive director DCAT. “He brings unique qualifications and experiences to his role that will help shape and support the organization’s programs and projects.”